PADAGIS ISRAEL Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PADAGIS ISRAEL, and what generic and branded alternatives to PADAGIS ISRAEL drugs are available?
PADAGIS ISRAEL has eighty-one approved drugs.
Summary for PADAGIS ISRAEL
US Patents: | 0 |
Tradenames: | 49 |
Ingredients: | 49 |
NDAs: | 81 |
Patent Litigation for PADAGIS ISRAEL: | See patent lawsuits for PADAGIS ISRAEL |
Drugs and US Patents for PADAGIS ISRAEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Padagis Israel | DESOXIMETASONE | desoximetasone | SPRAY;TOPICAL | 206441-001 | Jan 20, 2017 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Padagis Israel | TERCONAZOLE | terconazole | SUPPOSITORY;VAGINAL | 077149-001 | Mar 17, 2006 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Padagis Israel | NALOXONE HYDROCHLORIDE | naloxone hydrochloride | SPRAY, METERED;NASAL | 211951-001 | Jun 21, 2022 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Padagis Israel | CICLOPIROX | ciclopirox | CREAM;TOPICAL | 077364-001 | Mar 3, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Padagis Israel | ESTRADIOL | estradiol | GEL;TRANSDERMAL | 216524-003 | Nov 14, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Padagis Israel | DAPSONE | dapsone | GEL;TOPICAL | 212657-001 | Nov 1, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for PADAGIS ISRAEL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Vaginal Cream | 2% | ➤ Subscribe | 2009-12-23 |
Similar Applicant Names
Here is a list of applicants with similar names.